Heparin-Induced Thrombocytopenia in 7MM Forecast to 2032: Emerging Therapies and Epidemiological Insights

DUBLIN, Aug. 17, 2023 /PRNewswire/ — The “Heparin-Induced Thrombocytopenia – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. Heparin-induced Thrombocytopenia remains a challenging immunological syndrome with potentially…